Tobacco Regulation As Device Could Be Complicated By FDAMA - Burlington
This article was originally published in The Gray Sheet
Executive SummaryFDA's regulation of cigarettes as a drug delivery device is a "hard thing to reconcile" with the FDA Modernization Act, Bruce Burlington, director of the agency's Center for Devices and Radiological Health, said at the recently concluded Health Industry Manufacturers Association annual meeting in Rancho Mirage, California.
You may also be interested in...
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.
Cadila has filed for approval of saroglitazar for NASH in India. The drug, which could emerge as the first medicine for the indication if approved, is already being used by a million Indian patients for diabetic dyslipidemia and hypertriglyceridemia.